# Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock

> **NCT00320099** · PHASE3 · COMPLETED · sponsor: **University of Versailles** · enrollment: 508 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** recombinant human insulin
- **DRUG:** hydrocortisone
- **DRUG:** fludrocortisone
- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT00320099
- **Lead sponsor:** University of Versailles
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-02
- **Target enrollment:** 508 (ACTUAL)
- **Last updated:** 2010-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00320099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00320099, "Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00320099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*